FCRL4/FcRH4/IRTA1 Antibody [DyLight 594]
Novus Biologicals, part of Bio-Techne | Catalog # AF2426M

Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry
Label
DyLight 594 (Excitation = 593 nm, Emission = 618 nm)
Antibody Source
Polyclonal Goat IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human FCRL4/FcRH4
Gln16-Asp385
Accession # Q96PJ5
Gln16-Asp385
Accession # Q96PJ5
Specificity
Detects human FCRL4/FcRH4 in direct ELISAs. In direct ELISAs, less than 2% cross‑reactivity with recombinant human (rh) IRTA2, rhIRTA3, rhIRTA4, and rhIRTA5 is observed.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for FCRL4/FcRH4/IRTA1 Antibody [DyLight 594]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: FCRL4/FcRH4
Long Name
Fc Receptor-like protein 4
Alternate Names
CD307d, FcRH4, IGFP2, IRTA1
Gene Symbol
FCRL4
Additional FCRL4/FcRH4 Products
Product Documents for FCRL4/FcRH4/IRTA1 Antibody [DyLight 594]
Product Specific Notices for FCRL4/FcRH4/IRTA1 Antibody [DyLight 594]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...